Mechanism of action of Tripterygium Wilfordii polyglycoside on experimental endometriosis

Purpose of investigation: This study was designed to examine the therapeutic effectiveness and mechanism of action of Tripterygium Wilfordii polyglycoside (TWP) in the treatment of endometriosis.

Methods: An experimental endometriosis model was developed using New Zealand White rabbits where endometrial tissue was autotransplanted into the peritoneum. Six weeks after transplantation, a total of 22 rabbits were randomly placed into two groups: Group I (n=17) was treated with TWP (10 mg/kg/day) and Group 2 (n=5) served as the water-fed control for three successive months. The volume of endometrial implants was measured before and after administration of TWP and water. Immune and endocrine systems were investigated in the normal phase, six weeks after induction of endometriosis, and three months after TWP treatment and water administration.

Results: After treatment with TWP, the average volume of endometrial implants significantly decreased (p < 0.0001), and the antiendometrial antibody (EmAb) level decreased (p < 0.05) to near normal levels, but it did not decrease in the untreated controls. Serum FSH and LH levels also decreased after TWP treatment. Furthermore, electron microscopic examination of the pituitary ultrastructure revealed morphological changes in gonadotropic cells (G-cell) after treatment with TWP, and changes gradually disappeared four weeks after withdrawal of TWP.

Conclusion: This study indicates that TWP has both hormonal and immune system action that is effective as a medical treatment for experimental endometriosis by modulating both reproductive endocrine functions and immunosuppression that results in remission of the disease.

Tripterygium Wilfordii polyglycoside; Endometriosis; Medical treatment

[1] Kistner R. W.: "Endometriosis and infertility". Clin. Obstet. Gynecol., 1979, 22, 101.

[2] Dmowski W. P., Steele R. W., Baker G. F.: "Deficient cellular immunity in endometriosis". Am. J. Obstet. Gynecol., 1981, 141, 377.

[3] Steele R. W., Dmowski W. P., Marmer D. J.: "Immunologic aspects of human endometriosis". Am. J. Reprod. lmmunol., 1984, 6, 33.

[4] Gleicher N., El-Roeiy A., Confino E., Friberg J.: "ls endometnosis an autoimmune disease9" Obstet. Gynecol., 1987, 70, 115.

[5] Startseva N. V.: "Clinical immunological aspects of genital endometriosis". Akush. Ginekol. Mask., 1980, 3, 23.

[6] Hill J. A., Faris H. M. P., Schiff I., Anderson D. J.: "Charactenzation of leukocyte subpopulations in the peritoneal fluid of women with endometriosis". Fertil. Steril.,1988, 50, 216.

[7] Oosterlynck D. J., Cornillie F. J., Waer M., Vandeputte M., Koninckx P. R.: "Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium". Fertil. Steril, 1991,56, 45.

[8] Barbieri R. L., Ryan K. J.: "Danazol: Endocrine pharmacology and therapeutic application". Am. J. Obstet. Gynecol., 1981, 141, 453.

[9] Matalliotakis I., Panidis D., V lassis G., Neonaki M., Koumam takis E.: "Decreased sensitivity to insulin during treatment with danazol in women with endometriosis". Clin. Exp. Obstet Gynecol., 1997, 24, 160.

[10] Moghissi A. S.: "Treatment of endometriosis with estrogen-progestin combination and progestogens alone". Clin. Obstet. Gynecol., 1988, 31, 823.

[11] Henzl M. R.: "Gonadotropin-releasing hormone (GnRH) agonists in the management of endometriosis: A review". Clin. Obstet. Gynecol., 1988, 31, 840.

[12] Qian S. Z.: "Tripterygium Wilfordii, a Chinese herb effective in male fertility regulation". Contraception, 1987, 36, 335.

[13] Chen D. P., Wu Y. F., Di W.: "Treatment of endometriosis with P olyglycoside of Trierygium". Shanghai J. Tradi. Chinese. Med., 1994, 9, 6.

[14] Schenken R, S., Asch R. H.: "Surgical induction of endometriosis in the rabbits: effects on fertility and concentrations of peritoneal fluid prostaglandins". Fertil. Steril., 1980, 34, 581.

[15] Kennedy S. H., Starkey P. M., Sargent I. L., Hicks B. R., Barlow D. H.: "Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with Danazol and Nafarelin". Obstet. Gy necol., 1990, 75, 914.

[16] Treloar A. F., Schabdach D. G., Sansing S., Keller L. S.: "Superovulation of New Zealand white rabbits by continuous infusion of follicle-stimulating hormone, using a micro-osmotic pump" Lab. Anim. Sci., 1997, 47, 313.

[17] Badawy S. Z., Cuenca V., Stitzel A., Jacobs R. D., Tomar R. H.: "Autoimmune phenomena in infertile patients with endometriosis". Obstet. Gynecol., 1984, 63, 271.

[18] Weed J. C., Arquembourg P. C.: "Endometriosis: can it produce an autoimmune response resulting in infertility?" Clin. Obstet Gynecol., 1980, 23, 885.